Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL2017291 (GSK1210151A) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
ATPase family AAA domain containing 2/ATPase family AAA domain-containing protein 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2150837] [GtoPdb: 2719] [UniProtKB: Q6PL18] | ||||||||
ChEMBL | Binding affinity to biotinylated ATAD2A (981 to 1108 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method | B | 5 | pKd | >10000 | nM | Kd | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
bromodomain containing 2/Bromodomain-containing protein 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1293289] [GtoPdb: 1944] [UniProtKB: P25440] | ||||||||
ChEMBL | Binding affinity to biotinylated BRD2 BD2 (349 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method | B | 7.15 | pKd | 70.3 | nM | Kd | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
ChEMBL | Binding affinity to biotinylated BRD2 BD1 (72 to 205 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method | B | 7.26 | pKd | 54.8 | nM | Kd | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
ChEMBL | Displacement of FAM-labeled ZBA248 from BRD2 BD2 (349 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay | B | 7.3 | pKi | 49.6 | nM | Ki | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
ChEMBL | Displacement of FAM-labeled ZBA248 from BRD2 BD1 (72 to 205 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay | B | 8.05 | pKi | 9 | nM | Ki | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
ChEMBL | Binding affinity to human BRD2 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis | B | 6.3 | pIC50 | 501.19 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 2968-2972 [PMID:22437115] |
GtoPdb | - | - | 6.3 | pIC50 | 500 | nM | IC50 | Nature (2011) 478: 529-33 [PMID:21964340] |
ChEMBL | Inhibition of BRD2 (unknown origin) by fluorescence anisotrophy | B | 6.3 | pIC50 | 500 | nM | IC50 | J Med Chem (2015) 58: 1281-1297 [PMID:25559428] |
ChEMBL | Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD2 BD2 (1 to 473 residues)/BD1 Y113A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay | B | 6.7 | pIC50 | 199.53 | nM | IC50 | J Med Chem (2020) 63: 9020-9044 [PMID:32787145] |
ChEMBL | Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD2 BD1 (1 to 473 residues)/BD2 Y386A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay | B | 7.3 | pIC50 | 50.12 | nM | IC50 | J Med Chem (2020) 63: 9020-9044 [PMID:32787145] |
bromodomain containing 3/Bromodomain-containing protein 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1795186] [GtoPdb: 2725] [UniProtKB: Q15059] | ||||||||
ChEMBL | Binding affinity to biotinylated BRD3 BD2 (306 to 417 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method | B | 7.39 | pKd | 40.5 | nM | Kd | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
ChEMBL | Binding affinity to biotinylated BRD3 BD1 (24 to 144 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method | B | 7.53 | pKd | 29.8 | nM | Kd | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
ChEMBL | Displacement of FAM-labeled ZBA248 from BRD3 BD2 (306 to 417 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay | B | 7.65 | pKi | 22.3 | nM | Ki | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
ChEMBL | Displacement of FAM-labeled ZBA248 from BRD3 BD1 (24 to 144 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay | B | 8.14 | pKi | 7.2 | nM | Ki | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
ChEMBL | Binding affinity to BRD3 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis | B | 6.6 | pIC50 | 251.19 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 2968-2972 [PMID:22437115] |
GtoPdb | - | - | 6.6 | pIC50 | 250 | nM | IC50 | Nature (2011) 478: 529-33 [PMID:21964340] |
ChEMBL | Inhibition of BRD3 (unknown origin) by fluorescence anisotrophy | B | 6.6 | pIC50 | 250 | nM | IC50 | J Med Chem (2015) 58: 1281-1297 [PMID:25559428] |
ChEMBL | Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD3 BD2 (1 to 435 residues)/BD1 Y73A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay | B | 7.1 | pIC50 | 79.43 | nM | IC50 | J Med Chem (2020) 63: 9020-9044 [PMID:32787145] |
ChEMBL | Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD3 BD1 (1 to 435 residues)/BD2 Y348A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay | B | 7.5 | pIC50 | 31.62 | nM | IC50 | J Med Chem (2020) 63: 9020-9044 [PMID:32787145] |
bromodomain containing 4/Bromodomain-containing protein 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1163125] [GtoPdb: 1945] [UniProtKB: O60885] | ||||||||
ChEMBL | Binding affinity to biotinylated BRD4 BD2 (333 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method | B | 6.67 | pKd | 215 | nM | Kd | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
ChEMBL | Binding affinity to biotinylated BRD4 BD1 (44 to 168 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method | B | 7.28 | pKd | 52.8 | nM | Kd | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
ChEMBL | Inhibition of Cy5-linked JQ1 probe binding to recombinant human N-terminal TEV-cleavable hexa-histidine tagged BRD4 bromodomain2 after 60 mins by HTRF assay | B | 6.41 | pKi | 385 | nM | Ki | Bioorg Med Chem (2019) 27: 457-469 [PMID:30606676] |
ChEMBL | Displacement of FAM-labeled ZBA248 from BRD4 BD2 (333 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay | B | 7.13 | pKi | 74.8 | nM | Ki | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
ChEMBL | Inhibition of FAM-labeled ZBA248 binding to recombinant human N-terminal His6-tagged BRD4 bromodomain 2 (333 to 460 residues) expressed in Rosetta2 DE3 cells after 30 mins by Flourescence polarization assay | B | 7.13 | pKi | 74.8 | nM | Ki | J Med Chem (2017) 60: 3887-3901 [PMID:28463487] |
ChEMBL | Inhibition of tetra-acetylated Histone H4 peptide binding to recombinant human N-terminal TEV-cleavable hexa-histidine tagged BRD4 bromodomain1 after 60 mins by ALPHA screen assay | B | 7.21 | pKi | 61 | nM | Ki | Bioorg Med Chem (2019) 27: 457-469 [PMID:30606676] |
ChEMBL | Displacement of FAM-labeled ZBA248 from BRD4 BD1 (44 to 168 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay | B | 8.05 | pKi | 9 | nM | Ki | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
ChEMBL | Inhibition of FAM-labeled ZBA248 binding to recombinant human N-terminal His6-tagged BRD4 bromodomain 1 (44 to 168 residues) expressed in Rosetta2 DE3 cells after 30 mins by Flourescence polarization assay | B | 8.05 | pKi | 9 | nM | Ki | J Med Chem (2017) 60: 3887-3901 [PMID:28463487] |
ChEMBL | Inhibition of BRD4 in human whole blood assessed as reduction in LPS-induced IL-6 secretion preincubated for 30 mins followed by LPS stimulation and measured after 24 hrs by MSD assay | B | 5.9 | pIC50 | 1258.93 | nM | IC50 | J Med Chem (2021) 64: 12200-12227 [PMID:34387088] |
ChEMBL | Binding affinity to BRD4 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis | B | 6.1 | pIC50 | 794.33 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 2968-2972 [PMID:22437115] |
GtoPdb | - | - | 6.1 | pIC50 | 790 | nM | IC50 | Nature (2011) 478: 529-33 [PMID:21964340] |
ChEMBL | Inhibition of BRD4 (unknown origin) by fluorescence polarization assay | B | 6.1 | pIC50 | 790 | nM | IC50 | Bioorg Med Chem (2018) 26: 2937-2957 [PMID:29776834] |
ChEMBL | Binding affinity to human BRD4 1/2 bromodomain by fluorescence anisotropic assay | B | 6.1 | pIC50 | 790 | nM | IC50 | J Med Chem (2013) 56: 3217-3227 [PMID:23517011] |
ChEMBL | Inhibition of BRD4 (unknown origin) by fluorescence anisotrophy | B | 6.1 | pIC50 | 790 | nM | IC50 | J Med Chem (2015) 58: 1281-1297 [PMID:25559428] |
ChEMBL | Inhibition of BRD4 (unknown origin) by fluorescence anisotropy ligand displacement assay | B | 6.1 | pIC50 | 790 | nM | IC50 | Bioorg Med Chem Lett (2017) 27: 4051-4055 [PMID:28765013] |
ChEMBL | Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD4 BD2 (1 to 477 residues)/BD1 Y97A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay | B | 6.5 | pIC50 | 316.23 | nM | IC50 | J Med Chem (2020) 63: 9020-9044 [PMID:32787145] |
ChEMBL | Displacement of Alexa Fluor 647 labelled ligand from His6-tagged BRD4 BD2 (1 to 477 residues)/BD1 Y97A mutant (unknown origin) after 30 mins by TR-FRET assay | B | 6.56 | pIC50 | 274 | nM | IC50 | J Med Chem (2020) 63: 9045-9069 [PMID:32691589] |
ChEMBL | Displacement of FAM-labeled ZBA248 from BRD4 BD2 (333 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay | B | 6.65 | pIC50 | 226 | nM | IC50 | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
ChEMBL | Inhibition of FAM-labeled ZBA248 binding to recombinant human N-terminal His6-tagged BRD4 bromodomain 2 (333 to 460 residues) expressed in Rosetta2 DE3 cells after 30 mins by Flourescence polarization assay | B | 6.65 | pIC50 | 226 | nM | IC50 | J Med Chem (2017) 60: 3887-3901 [PMID:28463487] |
ChEMBL | Inhibition of BRD4 in human PBMC assessed as reduction in LPS-induced IL-6 secretion incubated for 18 to 24 hrs by MSD assay | B | 6.7 | pIC50 | 199.53 | nM | IC50 | J Med Chem (2021) 64: 12200-12227 [PMID:34387088] |
ChEMBL | Inhibition of BRD4 in human Raji cells assessed as reduction of MYC expression after 4 hrs | B | 6.89 | pIC50 | 130 | nM | IC50 | ACS Med Chem Lett (2013) 4: 835-840 [PMID:24900758] |
ChEMBL | Inhibition of BRD4 bromodomain-1 (unknown origin) by europium based LANCE TR-FRET assay | B | 6.97 | pIC50 | 107 | nM | IC50 | Bioorg Med Chem (2015) 23: 953-959 [PMID:25678016] |
ChEMBL | Inhibition of BRD4(1) (unknown origin) incubated for 4 hrs by (+)-JQ1 fluorescent ligand based fluorescence anisotrophy | B | 7 | pIC50 | 100 | nM | IC50 | J Med Chem (2015) 58: 1281-1297 [PMID:25559428] |
ChEMBL | Displacement of Alexa Fluor 647 labelled ligand from His6-thr-tagged BRD4 BD1 (1 to 477 residues)/BD2 Y390A mutant (unknown origin) after 30 mins by TR-FRET assay | B | 7.44 | pIC50 | 36 | nM | IC50 | J Med Chem (2020) 63: 9045-9069 [PMID:32691589] |
ChEMBL | Inhibition of FAM-labeled ZBA248 binding to recombinant human N-terminal His6-tagged BRD4 bromodomain 1 (44 to 168 residues) expressed in Rosetta2 DE3 cells after 30 mins by Flourescence polarization assay | B | 7.5 | pIC50 | 31.7 | nM | IC50 | J Med Chem (2017) 60: 3887-3901 [PMID:28463487] |
ChEMBL | Displacement of FAM-labeled ZBA248 from BRD4 BD1 (44 to 168 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay | B | 7.5 | pIC50 | 31.7 | nM | IC50 | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
ChEMBL | Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD4 BD1 (1 to 477 residues)/BD2 Y390A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay | B | 7.6 | pIC50 | 25.12 | nM | IC50 | J Med Chem (2020) 63: 9020-9044 [PMID:32787145] |
ChEMBL | Displacement of Alexa Fluor 647 labelled ligand from recombinant human N-terminal 6His-tagged BRD4-BD1 Y390A mutant (1 to 477 residue) expressed in Escherichia coli incubated for 30 mins by TR-FRET assay | B | 7.6 | pIC50 | 25.12 | nM | IC50 | J Med Chem (2021) 64: 12200-12227 [PMID:34387088] |
ChEMBL | Inhibition of His/FLAG-tagged BRD4 BD1 (unknown origin) using histone H4-TetraAcetylated-biotin peptide as substrate incubated for 20 mins by AlphaLISA assay | B | 7.74 | pIC50 | 18 | nM | IC50 | ACS Med Chem Lett (2016) 7: 145-150 [PMID:26985289] |
ChEMBL | Inhibition of BRD4 bromodomain 1 (unknown origin) | B | 7.74 | pIC50 | 18 | nM | IC50 | J Med Chem (2016) 59: 1271-1298 [PMID:26572217] |
ChEMBL | Inhibition of His-FLAG-tagged BRD4 binding domain1 (unknown origin) binding to H4-TetraAc-biotin peptide after 20 mins by AlphaLISA | B | 7.74 | pIC50 | 18 | nM | IC50 | ACS Med Chem Lett (2013) 4: 835-840 [PMID:24900758] |
bromodomain testis associated/Bromodomain testis-specific protein in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1795185] [GtoPdb: 2729] [UniProtKB: Q58F21] | ||||||||
ChEMBL | Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRDT BD2 (1 to 397 residues)/BD1 Y66A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay | B | 5.8 | pIC50 | 1584.89 | nM | IC50 | J Med Chem (2020) 63: 9020-9044 [PMID:32787145] |
ChEMBL | Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRDT BD1 (1 to 397 residues)/BD2 Y309A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay | B | 6.9 | pIC50 | 125.89 | nM | IC50 | J Med Chem (2020) 63: 9020-9044 [PMID:32787145] |
CREB binding protein/CREB-binding protein in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5747] [GtoPdb: 2734] [UniProtKB: Q92793] | ||||||||
ChEMBL | Binding affinity to biotinylated CREBBP (1043 to 1159 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method | B | 5.51 | pKd | 3084 | nM | Kd | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
phosphodiesterase 4B/Phosphodiesterase 4B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL275] [GtoPdb: 1301] [UniProtKB: Q07343] | ||||||||
ChEMBL | Inhibition of PDE4B | B | 5.4 | pIC50 | 3981.07 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 2968-2972 [PMID:22437115] |
ChEMBL data shown on this page come from version 32:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]